Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0012|29|8|667-677

ISSN： 0902-0063

Source： CLINICAL TRANSPLANTATION (ELECTRONIC), Vol.29, Iss.8, 2015-08, pp. : 667-677

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and efficacy of the switch to generic mycophenolate mofetil and tacrolimus in heart transplant patients

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 7, 2015-07 ,pp. : 619-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 812-822

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enteric‐coated mycophenolate sodium given in combination with tacrolimus has a lower incidence of serious infections in Asian renal‐transplant recipients compared with mycophenolate mofetil

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. S183, 2015-05 ,pp. : 1-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mycophenolate Mofetil and Post-Transplant Glomerular Disease

By  

Nephron Clin Pract, Vol. 98, Iss. 3, 2004-11 ,pp. : c59-c60

Karger

Access to resources Recommend Favorite

Tacrolimus and the Risk of Solid Cancers After Liver Transplant: A Dose Effect Relationship

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 3, 2015-03 ,pp. : 678-686

John Wiley & Sons Inc

Access to resources Recommend Favorite